Aptamer Circuit‐Engineered Bio‐Nanovesicles With Self‐Promoted Tumor‐Targeting Loop for Efficient Immunogenic Chemotherapy
Small Methods · 2026
DOI: 10.1002/smtd.70838 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small Methods, 2026. Verfasst von Shuxuan Shao und 7 weiteren Autor:innen. Beteiligte Einrichtung: Molecular Science and Biomedicine Laboratory (MBL), State Key Laboratory of Chemo/Biosensing, FuRong Laboratory, College of Biology, Aptamer Engineer…. Hauptthemen laut MEDLINE: Aptamers, Nucleotide, Doxorubicin, Drug Delivery Systems, Extracellular Vesicles. Die Arbeit nennt 45 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Scientific Research Program of FuRong Laboratory, Fundamental and Interdisciplinary Disciplines Breakthrough Plan of the Ministry of Education of China.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Targeted delivery of chemodrugs to tumor sites is highly desirable for efficient chemotherapy. Extracellular vesicles (EVs)‐based carrier is an ideal candidate for drug delivery in cancer therapy. However, the insufficient tumor‐targeting capability remains to be solved. Herein, we designed an aptamer circuit with cascade recognition capacity to guide the vesicles for tumor targeting. The sequential signal transduction triggered by the specific binding between aptamers and their targets leads to the preferential binding of vesicles with cancerous cells rather than noncancerous cells with fewer targets. Moreover, a self‐promoted tumor‐targeting loop induced by Doxorubicin Hydrochloride (DOX) released from vesicles further amplified the targeting capability of the vesicle‐based drug carrier to tumor sites through up‐regulating PDL1 marker on the surface of tumor cells. Ultimately, the accumulation of DOX in tumor cells resulted in the immunogenic cell death (ICD) for evoking anti‐tumor immune response. Overall, this work presents a self‐promoted tumor‐targeting strategy for vesicle‐based carrier by coupling the cascade recognition and tumor‐targeting loop, which improves the therapeutic effect of immunogenic chemotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Molecular Science and Biomedicine Laboratory (MBL), State Key Laboratory of Chemo/Biosensing, FuRong Laboratory, College of Biology, Aptamer Engineering Center of Hunan Province, Hunan University, Changsha, Hunan, China.
- Department of Pathology, Xiangya School of Medicine, Changde Hospital, Central South University (The First People's Hospital of Changde City), Changde, Hunan, China.
- Zhejiang Key Laboratory of Functional Nucleic Acids for Basic and Clinical Application, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, Zhejiang, China.
ORCID-Profile: Qiaoling Liu
Förderung
- National Natural Science Foundation of China
- Scientific Research Program of FuRong Laboratory
- Fundamental and Interdisciplinary Disciplines Breakthrough Plan of the Ministry of Education of China
- Major Science and Technology Project in Medical and Health of the Zhejiang Province
- Analytical Instrumentation Center of Hunan University
Zitieren
APA
Shao, S., Zhang, C., Du, W., Zeng, J., Liu, S., Yang, F., Liu, Q., & Tan, W. (2026). Aptamer Circuit‐Engineered Bio‐Nanovesicles With Self‐Promoted Tumor‐Targeting Loop for Efficient Immunogenic Chemotherapy. Small Methods. https://doi.org/10.1002/smtd.70838
Vancouver
Shao S, Zhang C, Du W, Zeng J, Liu S, Yang F, et al. Aptamer Circuit‐Engineered Bio‐Nanovesicles With Self‐Promoted Tumor‐Targeting Loop for Efficient Immunogenic Chemotherapy. Small Methods. 2026. doi:10.1002/smtd.70838
BibTeX
@article{Shao2026,
author = {Shao, Shuxuan and Zhang, Cao and Du, Wei and Zeng, Jian and Liu, Shuang and Yang, Fan and Liu, Qiaoling and Tan, Weihong},
title = {Aptamer Circuit‐Engineered Bio‐Nanovesicles With Self‐Promoted Tumor‐Targeting Loop for Efficient Immunogenic Chemotherapy},
journal = {Small Methods},
year = {2026},
doi = {10.1002/smtd.70838}
}
EUVIMED